Investors - Press Releases
|View printer-friendly version|
Tabula Rasa HealthCare to Provide Innovative Medication Risk Mitigation Technology to National Primary Care Network MDVIP
Medication problems caused by dangerous drug interactions are a major cause of hospitalization and death in the U. S. TRHC's MedWise technology identifies patients' risk for multi-drug interactions before they occur, helping physicians make safer prescribing choices.
"The MedWise CMM Program will assist MDVIP Plus physicians to optimize medication regimens by calculating patients' MedWise Risk Scores™ (MRS) at multiple points of care," said TRHC Chairman and CEO
The odds of an adverse drug event increase by as much as 8.6 percent per unit of MedWise Risk Score. On average, MDVIP patients see a 2-point decrease in MRS when completing a medication safety review, which includes recommendations such as change or discontinuation of a medication and modifying time of medication administration. Each MRS unit corresponds to roughly
"We are pleased to make available to our Plus practices TRHC's MedWise Comprehensive Medication Management Program," said
Source: Bankes, D.L.; Jin, H.; Finnel, S.; Michaud, V.; Knowlton, C.H.; Turgeon, J.; Stein, A. Association of a Novel Medication Risk Score with Adverse Drug Events and Other Pertinent Outcomes Among Participants of the Programs of All-Inclusive Care for the Elderly. Pharmacy 2020, 8, 87.
This press release includes forward-looking statements that we believe to be reasonable as of today's date, including statements regarding Medication Risk Mitigation technology. Such statements are identified by use of the words "anticipates," "believes," "estimates," "expects," "intends," "plans," "predicts," "projects," "should," and similar expressions. These forward-looking statements are based on management's expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the
TRHC Media Contact: Dianne Semingson, firstname.lastname@example.org ,T: (215) 870-0829; TRHC Investor Contact: Frank Sparacino, email@example.com